ISSN 2398-2950      

Hypercalcemia: overview



  • Persistently raised ionized calcium concentrations.
  • Cause: multiple causes including neoplasia, renal failure, granulomatous disease, hypoadrenocorticism, hypervitaminosis D and others.
  • Diagnosis: defined by measurement of ionized calcium concentrations, but other tests may be required to identify the underlying cause.
  • Signs: may include anorexia, lethargy, weight loss, sometimes polyuria/polydipsia, and other signs dependent upon cause.
  • Treatment: fluid therapy, frusemide diuresis, glucocorticoids, or bisphosphonates may be used palliatively; other treatments will depend on underlying cause.
  • Prognosis: variable according to cause, but persistent untreated hypercalcemia may lead to renal failure, urolithiasis and organ mineralization.



  • Osteolysis: from neoplasia or bone infection.
  • Neoplasia (hypercalcemia of malignancy): various tumors release parathyroid hormone (PTH) mimetics, such as PTH-related peptide (PTH-rp):
  • Primary hyperparathyroidism Primary hyperparathyroidism: inappropriate secretion of parathyroid hormone (PTH) by a functional parathyroid tumor, usually an ademoma Adenoma / adenocarcinoma.
  • Hypervitaminosis D (dietary over-supplemetation; rodenticide ingestion Vitamin D poisoning (cholecalciferol)).
  • Advanced chronic renal disease Kidney: chronic kidney disease may result in tertiary hyperparathyroidism, characterized by sustained hyperplasia of the parathyroid resulting in loss of sensitivity to calcium and autonomous release of PTH.
  • Granulomatous diseases, eg mycobacteriosis and fungal infections may cause hypercalcemia.
  • Large proportion of cases are idiopathic.


  • Hypercalcemia is the result of increased uptake from gastrointestinal system, excessive release of from bone, or decreased renal excretion.
  • PTH and PT-rp activate osteoclasts, with release of calcium from bone. These agents also promote renal conservation of calcium and stimulate the synthesis of active Vitamin D Vitamin D by the kidneys.
  • Vitamin D and its analogues increase gastrointestinal uptake of calcium. At high levels, calcium is also released from bone.
  • Osteolytic processes result in release of calcium and phosphorus from bone.
  • Hypercalcemia impairs renal responsiveness to anti-diuretic hormone (ADH), resulting in compromised renal concentrating ability, and compensatory polydipsia.
  • Excessive circulating calcium, on exceeding a critical Ca x P solubility product, leads to calcium deposition in tissues such as lungs, kidney, gastric mucosa, blood vessel walls, and myocardium (metastatic calcification).
  • Kidney and lung damage from such metastatic calcification can prove fatal.
  • Excess extracellular calcium reduces membrane excitability, resulting in dysrhythmias and muscle weakness.


  • Very variable according to cause and severity of hypercalcemia:
    • Vitamin D intoxication can be very rapid, with rapid tissue mineralization.
    • Renal failure typically has a more chronic course.


This article is available in full to registered subscribers

Sign up now to obtain ten tokens to view any ten Vetlexicon articles, images, sounds or videos, or Login


This article is available in full to registered subscribers

Sign up now to obtain ten tokens to view any ten Vetlexicon articles, images, sounds or videos, or Login


This article is available in full to registered subscribers

Sign up now to obtain ten tokens to view any ten Vetlexicon articles, images, sounds or videos, or Login

Further Reading


Refereed papers

  • Recent references from PubMed and VetMedResource.
  • Hostutler R A, Chew D J, Jaeger J Q et al (2005) Uses and effectiveness of pamidronate disodium for treatment of dogs and cats with hypercalcemia. JVIM 19 (1), 29-33 PubMed.
  • Bolliger A P, Graham P A, Richard V et al (2002) Detection of parathyroid hormone-related protein in cats with humoral hypercalcemia of malignancy. Vet Clin Pathol 31 (1), 3-8 PubMed.
  • Smith S A, Freeman L C, & Bagladi-Swanson M (2002) Hypercalcemia due to latrogenic secondary hypoadrenocorticism and diabetes mellitus in a cat. J Am Anim Hosp Assoc 38 (1), 41-44 PubMed.
  • Midkiff A M, Chew D J, Randolph J F et al (2000) Idiopathic hypercalcemia in cats. J Vet Intern Med 14 (6), 619-626 PubMed.
  • Savary K C, Price G S & Vaden S L (2000) Hypercalcemia in cats: a retrospective study of 71 cases (1991-1997). J Vet Intern Med 14 (2), 184-189 PubMed.
  • Sueda M T & Stefanacci J D (2000) Ultrasound evaluation of the parathyroid glands in two hypercalcemic cats. Vet Radiol Ultrasound 41 (5) 448-451 PubMed.
  • McClain H M, Barsanti J A & Bartges J W (1999) Hypercalcemia and calcium oxalate urolithiasis in cats: a report of five cases. J Am Anim Hosp Assoc 35 (4), 297-301 PubMed.
  • Mealey K L, Willard M D, Nagode L A et al (1999) Hypercalcemia associated with granulomatous disease in a cat. J Am Vet Med Assoc 215 (7), 959-962 PubMed.
  • Kallet A J, Richter K P, Feldman E C et al (1991) Primary hyperparathyroidism in cats: seven cases (1984-1989). J Am Vet Med Assoc 199 (12), 1767-1771 PubMed.

Other sources of information

  • Schenick P A & Chew D J (2012) Investigation of hypercalcemia and hypocalcemia.In: BSAVA Manual of Canine and Feline Endocrinology. 4th edn. C T Mooney & M E Peterson (eds), BSAVA, England, pp 221-233.

Can’t find what you’re looking for?

We have an ever growing content library on Vetlexicon so if you ever find we haven't covered something that you need please fill in the form below and let us know!


To show you are not a Bot please can you enter the number showing adjacent to this field

 Security code